Vaccines Procurement Intelligence Is Revenues To Grow At Nearly 4.7% From 2023 to 2030

Vaccines Procurement Intelligence

The vaccines category is anticipated to grow at a CAGR of 4.7% from 2023 to 2030.

They can be classified mainly into six types – Live-attenuated, inactivated, sub-unit, toxoid, viral vector, and messenger RNA (mRNA) vaccines. Among these, the mRNA sector held the largest share of 39% in 2022. The growth of the category is mainly attributed to the rising requirement for effective immunization, increasing R&D investments coupled with technological advancements, and a wider accessibility of the product especially in lower-income countries. In recent times, the emergence of new COVID variants and other infectious diseases such as “Disease X”, Nipah virus, Ebola, Crimean-Congo Hemorrhagic Fever, Rift Valley Fever (RVF), etc. are further boosting the product demand.

Order your copy of the Vaccines category procurement intelligence report 2023-2030, published by Grand View Research, to get more details regarding day one, quick wins, portfolio analysis, key negotiation strategies of key suppliers, and low-cost/best-cost sourcing analysis

Vaccines Procurement Intelligence Report Scope

The Vaccines category is expected to have pricing growth outlook of 6% – 10% (Annually) from 2023 to 2030, with below pricing models.

Cost plus model
competitive pricing
Supplier Selection Scope of Report

Cost and pricing
past engagements
productivity
geographical presence
Supplier selection criteria of Report

Type of diseases covered (hepatitis, dengue, covid, etc)
certifications
production capacity
operational and functional capabilities
the technology used
others
Vaccines Procurement Intelligence Report Coverage

Grand View Research will cover the following aspects in the report:

Market Intelligence along with emerging technology and regulatory landscape
Market estimates and forecasts from 2022 to 2030
Growth opportunities, trends, and driver analysis
Supply chain analysis, supplier analysis with supplier ranking and positioning matrix, supplier’s recent developments
Porter’s 5 forces
Pricing and cost analysis, price trends, commodity price forecasting, cost structures, pricing model analysis, supply and demand analysis
Engagement and operating models, KPI, and SLA elements
LCC/BCC analysis and negotiation strategies
Peer benchmarking and product analysis
Market report in PDF, Excel, and PPT and online dashboard versions
Vaccines Procurement Cost and Supplier Intelligence

Cost modelling is an effective method that may be used to simulate bottlenecks, improve production efficiency, and get a deeper understanding of the processes involved in making vaccines. From research to GMP manufacturing stages, different types of direct and indirect costs are involved in the process. The main key cost components associated with manufacturing are capital, labor, materials, consumables, and other costs. Capital costs can include components such as equipment, capital estimates (such as installation, pipework, HVAC, power, and building), and validation. Capital costs are the largest component in the process accounting for between 41 – 49% of the total cost structure. Consumables can include filters, membranes, single-use components, etc. Other costs can include R&D, marketing and licensing, packaging, distribution, and engineering, which can vary based on the specifications and technology of the individual product.

According to Biopharm Services’ study, it was also found that the cost per dose is higher for stainless steel equipment. This is mainly attributed to factors such as higher capital and labor contribution compared to consumables and materials. For instance, in the case of inactivated vaccines, a facility with a lower utilization rate, using stainless steel processes, the capital charge and labor accounted for 48% and 14% respectively. Whereas, under the same conditions, in a facility using single-use processes, the capital and labor costs accounted for 41% and 9% respectively. In March 2023, the prices for Moderna’s COVID-19 vaccine were around USD 130 per dose. In September 2023, most of the manufacturers priced their COVID-19 vaccine shots between USD 120 – 130 per dose.

List of Key Suppliers

GlaxoSmithKline plc
Pfizer Inc.
Sanofi S.A.
Merck & Co., Inc.
AstraZeneca plc
Serum Institute of India Pvt. Ltd
Moderna, Inc.
BioNTech SE
Johnson & Johnson
Emergent BioSolutions Inc.
Sinovac Biotech Ltd.
Chongqing Zhifei Biological Products Co.,Ltd.
Add-on Services provided by Grand View Research Pipeline:

Should Cost Analysis
Component wise cost break down for better negotiation for the client, highlights the key cost drivers in the market with future price fluctuation for different materials (e.g.: steel, aluminum, etc.) used in the production process

Rate Benchmarking
Offering cost transparency for different products / services procured by the client. A typical report involves 2-3 case scenarios helping clients to select the best suited engagement with the supplier

Salary Benchmarking
Determining and forecasting salaries for specific skill set labor to make decision on outsourcing vs in-house.

Supplier Newsletter
A typical newsletter study by capturing latest information for specific suppliers related to: M&As, technological innovations, expansion, litigations, bankruptcy etc.

Browse through Grand View Research’s collection of procurement intelligence studies:

Disposable Medical Gloves Procurement Intelligence Report, 2023 – 2030 (Revenue Forecast, Supplier Ranking & Matrix, Emerging Technologies, Pricing Models, Cost Structure, Engagement & Operating Model, Competitive Landscape)
Loyalty Programs Procurement Intelligence Report, 2023 – 2030 (Revenue Forecast, Supplier Ranking & Matrix, Emerging Technologies, Pricing Models, Cost Structure, Engagement & Operating Model, Competitive Landscape)
Helium Procurement Intelligence Report, 2023 – 2030 (Revenue Forecast, Supplier Ranking & Matrix, Emerging Technologies, Pricing Models, Cost Structure, Engagement & Operating Model, Competitive Landscape)
Brief about Pipeline by Grand View Research:

A smart and effective supply chain is essential for growth in any organization. Pipeline division at Grand View Research provides detailed insights on every aspect of supply chain, which helps in efficient procurement decisions.

Our services include (not limited to):

Market Intelligence involving – market size and forecast, growth factors, and driving trends
Price and Cost Intelligence – pricing models adopted for the category, total cost of ownerships
Supplier Intelligence – rich insight on supplier landscape, and identifies suppliers who are dominating, emerging, lounging, and specializing
Sourcing / Procurement Intelligence – best practices followed in the industry, identifying standard KPIs and SLAs, peer analysis, negotiation strategies to be utilized with the suppliers, and best suited countries for sourcing to minimize supply chain disruptions

Vaccines Procurement Intelligence Is Revenues To Grow At Nearly 4.7% From 2023 to 2030